ROLE OF CAMP-DEPENDENT PROTEIN KINASE IN GROWTH CONTROL
营依赖性蛋白激酶在生长控制中的作用
基本信息
- 批准号:6435167
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:analog antineoplastics carcinoma cell differentiation cell growth regulation chemical carcinogenesis cyclic AMP cytotoxicity enzyme structure growth inhibitors isozymes leukemia multidrug resistance neoplasm /cancer pharmacology neoplastic cell pharmacokinetics protein kinase A sarcoma tissue /cell culture transfection /expression vector viral carcinogenesis
项目摘要
Our long term goal is to understand the regulation of cell growth by cAMP-dependent protein kinase (PKA) by an in-depth investigation of the structure, function and expression of the regulatory (R) and catalytic (C) subunits of PKA. Two isoforms of PKA, PKA-I and PKA-II, share a common catalytic (C) subunit but contain distinct regulatory (R) subunits, RI and RII, respectively. It is known that expression of PKA-I and its regulatory subunit, RIa is increased in human cancer cell lines, in primary tumors, and in cells after transformation. Our studies revealed the following: (1) Use of antisense strategy: RIa antisense oligodeoxynucleotide or antisense RIa gene overexpression is used to demonstrate the sequence-specific inhibition of RIa gene expression and in vivo tumor growth inhibition. The loss of RIa by the antisense resulted in rapid increase in RIIb and PKA-IIb holoenzyme. Pulse-chase experiments demonstrated that RIIb protein increased its half-life 3-6 fold in antisense treated cells. Thus, RIIb in the holoenzyme complex is stabilized, exhibiting an increased half-life. Through this biochemical adaptation, in the antisense-treated cancer cells, the ratio of PKA-I to PKA-II changes to that similar to that of normal cells.; (2) Recombinant gene technology: Retroviral-vector mediated overexpression of wild type and point-mutated RIa, RIIa, RIIb and C subunits of PKA to demonstrate distinctive roles of the R subunit isoforms in cell growth, differentiation, and reverse transformation; and (3) Discovery of extracellular PKA (ECPKA):the free catalytic (C) subunit of PKA is excreted in conditioned medium of various cancer cells, and in serum of cancer patients; the ECPKA expression was upregulated 10-fold as compared with normal serum. Importantly, this study provided the means of modulating the ECPKA expression by changing expression of the intracellular PKA-I and PKA-II. Namely, (1) overexpression of RIa in expression vector, which upregulates intracellular PKA-I, can markedly upregulate ECPKA expression; (2) overexpression of RIIb, which downregulates PKA-I in the cell and reverts the transformed phenotype, downregulates ECPKA; and (3) A mutation in the Ca gene that prevents myristylation allows the intracellular PKA upregulation but blocks the ECPKA increase, suggesting that the N-terminal myristyl group of Ca is required for ECPKA expression. It was further shown that ECPKA upregulation is reduced in cancer cells maintaining hormone-dependency (a normal cell property), such as hormone-dependent breast cancer as compared to the hormone-independent breast cancer. These observations indicate that this phenomenon of ECPKA expression can provide innovative approach to cancer diagnosis, prognosis, and hormone-dependence detection (breast cancer).
我们的长期目标是通过深入研究PKA调节(R)和催化(C)亚单位的结构、功能和表达来了解cAMP依赖的蛋白激酶(PKA)对细胞生长的调控。PKA的两种亚型PKA-I和PKA-II共享一个共同的催化(C)亚基,但分别含有不同的调节(R)亚基RI和RII。已知PKA-I及其调节亚基RIA在人类癌细胞系、原发肿瘤和转化后的细胞中的表达增加。我们的研究发现:(1)反义策略的使用:利用RIA反义寡核苷酸或反义RIA基因的过表达来证明序列特异性地抑制RIA基因的表达,并在体内抑制肿瘤的生长。RIA反义缺失导致RIIb和PKA-IIb全酶迅速升高。脉冲追逐实验表明,RIIb蛋白在反义处理细胞中的半衰期增加了3-6倍。因此,全酶复合体中的RIIb是稳定的,表现出增加的半衰期。通过这种生化适应,在反义处理的癌细胞中,PKA-I/PKA-II的比例与正常细胞相似。(2)重组基因技术:逆转录病毒载体介导的PKA野生型和点突变的RIA、RIIA、RIIB和C亚基的过表达,展示了R亚基异构体在细胞生长、分化和逆转中的独特作用;(3)细胞外PKA的发现(ECPKA):在各种癌细胞的条件培养液中和癌症患者的血清中分泌PKA的自由催化(C)亚基;与正常血清相比,ECPKA表达上调10倍。重要的是,本研究提供了通过改变细胞内PKA-I和PKA-II的表达来调控ECPKA表达的方法。也就是说,(1)在表达载体中过表达RIA,上调细胞内PKA-I的表达,可以显著上调ECPKA的表达;(2)过表达RIIb,下调细胞内的PKA-I,并逆转转化的表型,下调ECPKA的表达;(3)阻止肉豆蔻酸化的Ca基因突变,允许细胞内PKA上调,但阻止ECPKA的增加,这表明ECPKA的表达需要钙的N端肉豆蔻花柱基团。进一步研究表明,与激素非依赖性乳腺癌相比,维持激素依赖性(一种正常细胞特性)的癌细胞,如激素依赖型乳腺癌,ECPKA上调减少。这些观察表明,ECPKA的这种表达现象可以为癌症的诊断、预后和激素依赖性检测(乳腺癌)提供创新的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Y S CHO-CHUNG其他文献
Y S CHO-CHUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Y S CHO-CHUNG', 18)}}的其他基金
SITE-SELECTIVE CAMP ANALOGS AS ANTINEOPLASTICS AND CHEMOPREVENTIVES
作为抗肿瘤药和化学预防药的位点选择性 Camp 类似物
- 批准号:
5200922 - 财政年份:
- 资助金额:
-- - 项目类别:
CAMP BINDING PROTEINS IN MAMMARY CANCER GROWTH CONTROL
CAMP 结合蛋白在乳腺癌生长控制中的作用
- 批准号:
3962974 - 财政年份:
- 资助金额:
-- - 项目类别:
SITE-SELECTIVE CAMP ANALOGS AS ANTINEOPLASTICS AND CHEMOPREVENTIVES
作为抗肿瘤药和化学预防药的位点选择性 Camp 类似物
- 批准号:
3813329 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISM OF CAMP ACTION IN GROWTH CONTROL, DIFFERENTIATION, AND GENE REGULATION
CAMP 在生长控制、分化和基因调控中的作用机制
- 批准号:
3774316 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF CAMP IN GROWTH CONTROL AND DIFFERENTIATION--GENE REGULATION
CAMP在生长控制和分化中的作用--基因调控
- 批准号:
3813353 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF CAMP IN GROWTH CONTROL AND DIFFERENTIATION--GENE REGULATION
CAMP在生长控制和分化中的作用--基因调控
- 批准号:
3808517 - 财政年份:
- 资助金额:
-- - 项目类别:
CRE OLIGONUCLEOTIDE AS TRANSCRIPTION FACTOR DECOY/TUMOR GROWTH INHIBITOR
CRE 寡核苷酸作为转录因子诱饵/肿瘤生长抑制剂
- 批准号:
6101058 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
The analysis of proteinuria caused by antineoplastics and the preventative effects with antihypertensive medications using the Japanese medical database
利用日本医学数据库分析抗肿瘤药物引起的蛋白尿及抗高血压药物的预防效果
- 批准号:
21K17258 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Expediting Drug Development by Profiling Novel Antineoplastics by Mass Spectrometry-based Biomarker Profiling
通过基于质谱的生物标志物分析来分析新型抗肿瘤药物,加速药物开发
- 批准号:
499958-2016 - 财政年份:2016
- 资助金额:
-- - 项目类别:
Engage Grants Program
Novel Nanoparticle Delivery System for Antineoplastics
新型抗肿瘤纳米颗粒输送系统
- 批准号:
6483914 - 财政年份:2002
- 资助金额:
-- - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6124630 - 财政年份:1998
- 资助金额:
-- - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
6329037 - 财政年份:1998
- 资助金额:
-- - 项目类别:
GLYCOLIPIDS AND CYTOTOXIC RESPONSE TO ANTINEOPLASTICS
糖脂和抗肿瘤药物的细胞毒性反应
- 批准号:
2747737 - 财政年份:1998
- 资助金额:
-- - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459680 - 财政年份:1990
- 资助金额:
-- - 项目类别:
POLYMORPHIC METABOLISM OF ANTINEOPLASTICS IN CHILDREN
儿童抗肿瘤药物的多态性代谢
- 批准号:
3459678 - 财政年份:1990
- 资助金额:
-- - 项目类别:














{{item.name}}会员




